GENERVON BIOPHARMACEUTICALS
Genervon is a clinical-stage biopharmaceutical company focused on novel treatments for neurodegenerative diseases and disorders.
GENERVON BIOPHARMACEUTICALS
Social Links:
Industry:
Biotechnology Health Care Medical Therapeutics
Address:
Pasadena, California, United States
Country:
United States
Website Url:
http://www.genervon.com
Total Employee:
1+
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Content Delivery Network Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS GoDaddy DNS
Similar Organizations
Annexin Pharmaceuticals
Annexin Pharmaceuticals AB (publ) is a world-leading biotechnology company.
Circe Biomedical
Circe Biomedical is a Biotechnology company.
Expression Therapeutics
Expression Therapeutics is a biotechnology company.
Geneius
Geneius is a Biotechnology company.
Palliative Drug Care
Palliative Drug Care is a pharmaceuticals & biotechnology health care company.
QLSF Biotherapeutics
QLSF Biotherapeutics is an immuno-oncology startup company.
Rosetta Inpharmatics
Rosetta Inpharmatics LLC is an informational genomics company.
Current Advisors List
Official Site Inspections
http://www.genervon.com Semrush global rank: 7.42 M Semrush visits lastest month: 501
- Host name: 198.49.23.144
- IP address: 198.49.23.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Genervon Biopharmaceuticals"
Genervon Biopharmaceuticals - Crunchbase Company Profile
Organization. Genervon Biopharmaceuticals . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. ... Genervon is a clinical-stage …See details»
Overview - Genervon
Genervon Biopharmaceuticals LLC 1055 E. Colorado Blvd., Suite 500, Pasadena, CA 91106 USA Phone: 323-721-5500, Fax: 323-721-9131 [email protected]See details»
Genervon - Wikipedia
Genervon Biopharmaceuticals is a pharmaceutical company based in Pasadena, CA, focused on creating drugs for diseases of the central human nervous system. It is best known for its experimental drug, GM604, which seeks to treat Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. See details»
Organization | Genervon Biopharmaceuticals, LLC
Genervon Biopharmaceuticals, ... Organization Overview. First Clinical Trial. 2011 NCT01221246. First Marketed Drug. None First NDA Approval. None Last Known Activity. 2013 Timeline < …See details»
Genervon Biopharmaceuticals - Contacts, Employees, Board …
Organization. Genervon Biopharmaceuticals . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. ... Genervon Biopharmaceuticals …See details»
Genervon Biopharmaceuticals LLC - Drug pipelines, Patents
Explore Genervon Biopharmaceuticals LLC with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, and 2 literature, Drug:Alirinetide. ... The statistics for drugs in the …See details»
Genervon Company Profile - Office Locations, Competitors ... - Craft
Genervon is a clinical-stage biopharmaceutical company. It discovers a naturally occurring regulator of the development of the human nervous system as well as develops and …See details»
Genervon Biopharmaceuticals - Crunchbase
Organization. Genervon Biopharmaceuticals . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Similar Companies. Edit Similar Companies …See details»
Genervon Biopharmaceuticals LLC - BioCentury Company Profiles
Nov 3, 2014 Genervon Biopharmaceuticals LLC - BioCentury Company Profiles for the biopharma industrySee details»
Genervon to Present GM6’s Effect in Modulating Alzheimer’s …
Mar 3, 2020 Genervon Biopharmaceuticals LLC 1055 E. Colorado Blvd., Suite 500, Pasadena, CA 91106 USA Phone: 323-721-5500, Fax: 323-721-9131 [email protected]See details»
Genervon Biopharmaceuticals LLC (Genervon Biopharmaceuticals …
了解Genervon Biopharmaceuticals LLC (Genervon Biopharmaceuticals LLC)公司的药物管线，治疗领域，技术平台，以及它的3项临床试验和2篇文献，药物:Alirinetide。 ... mRNA …See details»
Controversy Over ALS Drug Trial Highlights Urgent Need For …
Apr 23, 2015 To insure the integrity of data management and analysis per FDA requirements, Genervon contracted a specialized research organization (CRO). Genervon has submitted the …See details»
GM604 Is a Multi-Target Regulator That Provides a Novel …
Dec 8, 2017 PASADENA, Calif.--(BUSINESS WIRE)--Genervon Biopharmaceuticals LLC ("Genervon") is presenting its recent findings at the 28th national symposium on ALS/MND in …See details»
Pipeline - Genervon
Genervon Biopharmaceuticals LLC 1055 E. Colorado Blvd., Suite 500, Pasadena, CA 91106 USA Phone: 323-721-5500, Fax: 323-721-9131 [email protected]See details»
ALS Therapy Creator Genervon Focusing on Nerve Cell …
Mar 5, 2018 Genervon researchers developed a version of MNTF called GM6 that they are testing in clinical trials. The studies are looking at its safety and effectiveness as a …See details»
Genervon Shares Alzheimer’s Gene List Linked to Its GM6 Treatment
Jan 13, 2017 Genervon’s therapy candidate GM6 is the result of a focused search of master regulators of embryonic development. The protein factor, which constitutes the active site of a …See details»
What's New — Genervon
Genervon to Present GM6’s Effect in Modulating Alzheimer’s Disease at the ASENT 2021 Annual Meeting. PASADENA, CA, USA, February 22, 2021 -- The American Society for Experimental …See details»
Science — Genervon
Building on this core hypothesis, Genervon discovered what it believes is the naturally occurring regulator of the development of the human nervous system, called the “motoneuronotrophic …See details»
Press Releases (OLD) — Genervon
May 8, 2017 Genervon has identified 1,259 genes altered greater than 2-fold in SH-5YSY cells by GM6 including 89, 48, 46 and 9 specific genes associated with ALS, AD, PD and MS …See details»